Changing Possibilities in Haemophilia® - Novo Nordisk A/S
Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.
Headquartered in Denmark, Novo
novonordisk, novonordisk.com, Novo Nordisk, Novo, Nordisk, diabetes, diabetes care, drugs, drug, pharma drug, pharma manufacturing, pharmaceutical company, pharmaceutical, insulin, insulin delivery, haemostasis management, growth disorders, hormone replac
Is this your site? Certify your site and update informations
